Blue Water Acquisition Corp. IV (BWIV)
USD · NYSE:BWIVU
Price Range
$10.00
Shares
18.01M shares
Listing Price
$9.95
Listing date
Mar 20, 2026
Sector
Financials
About
Blue Water Acquisition Corp. IV (BWIV)
Blue Water Acquisition Corp. IV does not have significant operations.
It intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses in the biotechnology, healthcare, and technology industries.
The company was incorporated in 2025 and is based in Greenwich, Connecticut.
Blue Water Acquisition Corp. IV (BWIV) Overview
Ticker, listing venue and issuer profile
Offer & Key Dates
Pricing terms and IPO milestones
Change from offer price to today
Live Market Snapshot
Real-time price; headline % change is vs first trade (listing price)
USD · NYSE:NYSE:BWIV.U
Valuation & Multiples
Key valuation ratios and metrics
Financial Health
Balance sheet strength and liquidity
Risk Metrics
Volatility versus the market
Financial Highlights
Historical financial performance
Financial data is not available yet for this IPO.
Historical Data
Market history and supplemental quote data
| Date | Open | High | Low | Close | Adj. Close | Change | Volume |
|---|---|---|---|---|---|---|---|
| 2026-04-29 | $10.10 | $10.11 | $10.09 | $10.09 | $10.09 | -0.01 | 59,969 |
| 2026-04-28 | $10.10 | $10.16 | $10.08 | $10.10 | $10.10 | 0.00 | 179,326 |
| 2026-04-27 | $9.96 | $9.96 | $9.96 | $9.96 | $9.96 | 0.00 | 0 |
| 2026-04-24 | $9.96 | $9.96 | $9.96 | $9.96 | $9.96 | 0.00 | 5,086 |
| 2026-04-23 | $9.96 | $9.96 | $9.96 | $9.96 | $9.96 | 0.00 | 1,000 |
| 2026-04-22 | $9.92 | $9.92 | $9.92 | $9.92 | $9.92 | 0.00 | 103 |
| 2026-04-21 | $9.92 | $10.00 | $9.92 | $10.00 | $10.00 | +0.08 | 6,405 |
| 2026-04-20 | $9.95 | $9.95 | $9.95 | $9.95 | $9.95 | 0.00 | 0 |
| 2026-04-17 | $9.95 | $9.95 | $9.95 | $9.95 | $9.95 | 0.00 | 1,133 |
| 2026-04-16 | $9.94 | $9.94 | $9.94 | $9.94 | $9.94 | 0.00 | 0 |
| 2026-04-15 | $9.94 | $9.94 | $9.94 | $9.94 | $9.94 | 0.00 | 227 |
| 2026-04-14 | $9.92 | $9.92 | $9.92 | $9.92 | $9.92 | 0.00 | 313 |
| 2026-04-13 | $9.92 | $9.92 | $9.92 | $9.92 | $9.92 | 0.00 | 609 |
| 2026-04-10 | $9.92 | $9.92 | $9.92 | $9.92 | $9.92 | 0.00 | 724 |
| 2026-04-09 | $9.95 | $9.95 | $9.95 | $9.95 | $9.95 | 0.00 | 0 |
| 2026-04-08 | $9.95 | $9.98 | $9.93 | $9.95 | $9.95 | +0.00 | 1,841 |
| 2026-04-07 | $9.92 | $9.93 | $9.92 | $9.92 | $9.92 | 0.00 | 50,684 |
| 2026-04-06 | $9.95 | $9.95 | $9.95 | $9.95 | $9.95 | 0.00 | 0 |
| 2026-04-02 | $9.95 | $9.95 | $9.95 | $9.95 | $9.95 | 0.00 | 910 |
| 2026-04-01 | $9.92 | $9.98 | $9.92 | $9.98 | $9.98 | +0.06 | 2,638 |
| 2026-03-31 | $9.92 | $9.92 | $9.92 | $9.92 | $9.92 | 0.00 | 300,555 |
| 2026-03-30 | $9.92 | $9.92 | $9.92 | $9.92 | $9.92 | 0.00 | 3,245 |
| 2026-03-27 | $9.96 | $9.96 | $9.93 | $9.93 | $9.93 | -0.03 | 32,502 |
| 2026-03-26 | $10.30 | $10.30 | $9.95 | $9.96 | $9.96 | -0.34 | 6,827 |
| 2026-03-25 | $10.08 | $10.12 | $9.96 | $9.98 | $9.98 | -0.10 | 111,980 |
| 2026-03-24 | $9.97 | $9.97 | $9.94 | $9.95 | $9.95 | -0.02 | 82,894 |
| 2026-03-23 | $9.93 | $9.95 | $9.93 | $9.94 | $9.94 | +0.01 | 85,059 |
| 2026-03-20 | $9.95 | $9.95 | $9.93 | $9.93 | $9.93 | -0.02 | 4,345,767 |
SEC Filings
Official documents from SEC EDGAR
| Form | Filing Date | Document |
|---|---|---|
| 425 | Apr 28, 2026 | Filing |
| 8-K | Apr 28, 2026 | Current Report |
| SCHEDULE 13G | Apr 15, 2026 | Filing |
| SCHEDULE 13G | Apr 9, 2026 | Filing |
| 8-K | Mar 27, 2026 | Current Report |
| 8-K | Mar 25, 2026 | Current Report |
| 424B4 | Mar 20, 2026 | Prospectus |
| EFFECT | Mar 19, 2026 | Notice of Effectiveness |
| CERT | Mar 19, 2026 | Certification by an exchange approving securities for listing |
| 8-A12B | Mar 19, 2026 | Registration of securities |
Company Info
Contact and headquarters details
Leadership
Key executives and officers
Joseph Hernandez
Chief Executive Officer and Chairman of the Board of Directors
Martha F. Ross
Chief Financial Officer
Timothy N. Coulson
Director nominee
Trevor L. Hawkins
Director nominee
Laurent D. Hermouet
Director nominee
